Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 112,550

Sort by:

TIM-3 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “TIM-3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the TIM-3 Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Toll- Like Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Toll- Like Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Toll- Like Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Toll-Like Receptor 4 (TLR-4) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Toll-Like Receptor 4 (TLR-4) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Toll-Like Receptor 4 (TLR-4) Agonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Toll-Like Receptor 7, 8 (TLR-8) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Toll-Like Receptor 7, 8 (TLR-8) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Toll-Like Receptor 7, 8 (TLR-8) Agonist to enhance and expand business potential ...

December 2018 60 pages

Toll-Like Receptor 9 (TLR-9) Modulator -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Toll-Like Receptor 9 (TLR-9) Modulator-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Toll-Like Receptor 9 (TLR-9) Modulator R&D Please note: Certain sections in the ...

December 2018 60 pages

Toll-Like Receptor Modulators -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Toll-Like Receptor Modulators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Toll-Like Receptor Modulators. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Topoisomerase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Topoisomerase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Topoisomerase Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

TRAIL Receptor 1 & Receptor 2 Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “TRAIL Receptor 1 & Receptor 2 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... by identifying potential partners with progressing projects for TRAIL Receptor 1 & Receptor 2 Agonist to enhance and expand business potential ...

December 2018 60 pages

Transforming Growth Factor (TGF) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Transforming Growth Factor (TGF) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Transforming Growth Factor (TGF) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

Transforming Growth Factor Beta (TGFb) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Transforming Growth Factor Beta (TGFb) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Transforming Growth Factor Beta (TGFb) Inhibitor to enhance and expand business ...

December 2018 60 pages

Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist-Pipeline ... leading companies Assess challenges and opportunities that influence Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist ...

December 2018 60 pages

Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist-Pipeline ... leading companies Assess challenges and opportunities that influence Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist ...

December 2018 60 pages

Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ...

December 2018 60 pages

Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ...

December 2018 60 pages

TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist ... identifying potential partners with progressing projects for TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor ...

December 2018 60 pages

Tumor Necrosis Factor Alpha (TNF-a) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Tumor Necrosis Factor Alpha (TNF-a) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Tumor Necrosis Factor Alpha (TNF-a) Agonist to enhance and expand business potential ...

December 2018 60 pages

Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor-Pipeline Intelligence, 2019”, report provides ... identifying potential partners with progressing projects for Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor to enhance and expand ...

December 2018 60 pages

Ubiquitin conjugating enzyme Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Ubiquitin conjugating enzyme Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Ubiquitin Specific Proteases (USP) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Ubiquitin Specific Proteases (USP) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Ubiquitin Specific Proteases (USP) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

Vascular Adhesion Protein 1 (VAP-1) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Vascular Adhesion Protein 1 (VAP-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Vascular Adhesion Protein 1 (VAP-1) Inhibitor to enhance and expand business ...

December 2018 60 pages

Vascular Endothelial Growth Factor Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Vascular Endothelial Growth Factor Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Vascular Endothelial Growth Factor Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor-Pipeline Intelligence, 2019”, report provides ... by identifying potential partners with progressing projects for Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor to enhance and expand ...

December 2018 60 pages

Vasopressin Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Vasopressin Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Vasopressin Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Vasopressin V1 Receptor (V1R) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Vasopressin V1 Receptor (V1R) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Vasopressin V1 Receptor (V1R) Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Vasopressin V2 Receptor (V2R) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Vasopressin V2 Receptor (V2R) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Vasopressin V2 Receptor (V2R) Agonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Vasopressin V2 Receptor (V2R) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Vasopressin V2 Receptor (V2R) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Vasopressin V2 Receptor (V2R) Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Intelligence, 2019”, report ... potential partners with progressing projects for VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor to enhance and ...

December 2018 60 pages

Viral RNA Polymerase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Viral RNA Polymerase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Viral RNA Polymerase Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist to enhance and expand business ...

December 2018 60 pages

Voltage-Dependent Calcium Channel Blockers -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Voltage-Dependent Calcium Channel Blockers. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Voltage-Dependent T-Type Calcium Channel Blockers-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Voltage-Dependent T-Type Calcium Channel Blockers R&D Please note: Certain sections in ...

December 2018 60 pages

Voltage-Gated Sodium Channel Blockers -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Voltage-Gated Sodium Channel Blockers. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Wnt Signaling Pathway Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Wnt Signaling Pathway Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Wnt Signaling Pathway Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Xanthine Oxidase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Xanthine Oxidase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Xanthine Oxidase Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Factor VIII Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Factor VIII Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Factor VIII Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

Congenital Hyperinsulinism - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Congenital Hyperinsulinism' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

December 2018 154 pages

Down Syndrome - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Dravet Syndrome' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2018 149 pages

Cholangiocarcinoma - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Cholangiocarcinoma' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2018 178 pages

Limb-Girdle Muscular Dystrophy - Market Outlook, Market Forecast And Competitve Landscape Report - 20185 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Limb-girdle Muscular Dystrophy' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

December 2018 184 pages

Neuromyelitis Optica - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Neuromyelitis Optica' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... specific treatment and disease management for the patients with Neuromyelitis Optica in the US, Europe, Japan, and China. Future treatment paradigm and ...

December 2018 151 pages

Primary Hyperoxaluria Type 1 - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Primary Hyperoxaluria Type 1' - Market Outlook, Market Forecast ... treatment and disease management for the patients with Primary Hyperoxaluria Type 1 in the US, Europe, Japan, and ... biomarkers. Key patient segment and market based on type, severity and stages of the disease. Disease ...

December 2018 184 pages

Prurigo Nodularis - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Prurigo Nodularis' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... specific treatment and disease management for the patients with Prurigo Nodularis in the US, Europe, Japan, and China. Future treatment paradigm and ...

December 2018 184 pages

X-Linked Adrenoleukodystrophy - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'X-linked Adrenoleukodystrophy' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises ... specific treatment and disease management for the patients with X-linked Adrenoleukodystrophy in the US, Europe, Japan, and China. Future treatment ...

December 2018 208 pages

Alzheimers Disease - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

... Knowledge Partners 'ALZHEIMERS DISEASE' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of the Disease overview, classifications, ... and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base ...

December 2018 172 pages

Asthma - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Asthma' - Market Outlook, Market Forecast and Competitive ... launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, ... Mortality 11 years of epidemiology and market projections Incidence/ Prevalence patient population Mortality, ...

December 2018 154 pages

Bladder Cancer - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Bladder Cancer' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2018 185 pages

Breast Cancer - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Breast Cancer' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2018 174 pages

Colorectal Cancer - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Colorectal Cancer' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2018 149 pages

Diabetes - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Diabetes' - Market Outlook, Market Forecast and Competitive ... launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, ... Mortality 11 years of epidemiology and market projections Incidence/ Prevalence patient population Mortality, ...

December 2018 183 pages

End Stage Renal Disease (Esrd) - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

... 'END STAGE RENAL DISEASE (ESRD)' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of the Disease overview, classifications, stages ... segment and market based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy, ...

December 2018 197 pages

Filters

Clear all